The European Patent Office (EPO) has granted WEHI a patent for CISH knockout (KO) in Natural Killer (NK) cells which is exclusively licensed to ONK Therapeutics for cell immunotherapy purposes, giving ...
NEW YORK and CAMBRIDGE, England, May 1, 2025 /PRNewswire/ -- Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancers, presented data from a ...
a) Significant different from CISH ratio in a two tailed, paired t-test (N = 348, P < 0.001) b) Significant different from CISH ratio in a two tailed, paired t-test (N = 350, P = 0.001) c) Not ...
Background Chromogenic in situ hybridization (CISH) is fast becoming a well established technique for easy and sensitive determination of HER2 gene status in breast cancer. However, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results